These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 5353477

  • 1. Systemic and coronary hemodynamic effects of 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene)-hydrochloride (Intensain, A-27053).
    Rowe GG, Terry W, Stenlund RR, Thomsen JH, Querimit AS.
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):99-103. PubMed ID: 5353477
    [No Abstract] [Full Text] [Related]

  • 2. Systemic and coronary hemodynamic effects of 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene)-hydrochloride (Intensain, A-27053).
    Rowe GG, McKenna DH, Sialer S, Corliss RJ.
    Vasc Dis; 1967 Jun; 4(3):183-90. PubMed ID: 6028828
    [No Abstract] [Full Text] [Related]

  • 3. [Effects of new vasoactive drug, 3(beta-diethylamino-ethyl)-4-methyl-7-(carbethoxy-methoxy)-2-oxy-1,2-chromen HC1 (Intensain) on the coronary circulation in dogs].
    Campus S, Pandolfo G, Dessy P, Gagna C, Uslenghi E.
    Minerva Cardioangiol; 1967 Nov; 15(11):722-4. PubMed ID: 5616009
    [No Abstract] [Full Text] [Related]

  • 4. Systemic and coronary hemodynamic effects of perhexiline.
    Rowe GG, Spring DA, Afonso S.
    Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):377-93. PubMed ID: 4921275
    [No Abstract] [Full Text] [Related]

  • 5. [Animal experiment study on the coronary and circulatory effect of dipyridamole, carbocromen, hexobendine, dilazep and glucagon].
    Reploh HD.
    Arzneimittelforschung; 1973 May; 23(5):629-39. PubMed ID: 4740201
    [No Abstract] [Full Text] [Related]

  • 6. Effects of nitroglycerin, dipyridamole, carbocromen, xanthinol nicotinate, and butallylonal on venous return.
    Holtermann W, Lochner W.
    Arzneimittelforschung; 1972 Aug; 22(8):1376-81. PubMed ID: 4629177
    [No Abstract] [Full Text] [Related]

  • 7. The systemic and coronary hemodynamic effects of lidoflazine.
    Thomsen JH, Stenlund RR, Corliss RJ, Sialer S, Rowe GG.
    Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):15-23. PubMed ID: 5650324
    [No Abstract] [Full Text] [Related]

  • 8. Cardiovascular effects of Cassella 7657 and its interaction with adenosine, NAD and aminophylline in dogs.
    Afonso S, Hansing CE, Rowe GG.
    Arch Int Pharmacodyn Ther; 1973 Dec; 206(2):299-310. PubMed ID: 4360340
    [No Abstract] [Full Text] [Related]

  • 9. Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics.
    Petta JM, Zaccheo VJ.
    J Pharmacol Exp Ther; 1971 Feb; 176(2):328-38. PubMed ID: 4998691
    [No Abstract] [Full Text] [Related]

  • 10. Systemic and coronary hemodynamic effects of isoproterenol in control animals and those pretreated with a MAO inhibitor (pargyline hydrochloride).
    McKenna DH, Afonso S, Jaramillo CV, Crumpton CW, Rowe GG.
    Arch Int Pharmacodyn Ther; 1966 Aug; 162(2):275-82. PubMed ID: 5968511
    [No Abstract] [Full Text] [Related]

  • 11. Effect of a coronary vasodilator drug (carbochromen) on blood flow and oxygen extraction in acute myocardial infarction.
    Parratt JR, Ledingham IM, McArdle CS.
    Cardiovasc Res; 1973 May; 7(3):401-7. PubMed ID: 4722935
    [No Abstract] [Full Text] [Related]

  • 12. Proceedings: Comparison of a coronary vasodilator drug (carbochromen) and a cardiac stimulant (oxyfedrin) on blood flow and oxygen extraction in experimental myocardial infarcts.
    Ledingham IM, McArdle CS, Parratt JR.
    Br J Pharmacol; 1972 Feb; 44(2):323P-324P. PubMed ID: 4668599
    [No Abstract] [Full Text] [Related]

  • 13. Systemic and hemodynamic effects of oral hexobendine in dogs.
    Hansing CE, Folts JD, Afonso S, Rowe GG.
    Arzneimittelforschung; 1972 Feb; 22(2):398-402. PubMed ID: 5067494
    [No Abstract] [Full Text] [Related]

  • 14. Coronary and systemic hemodynamic effects of propranolol and practolol compared in the resting, conscious dog.
    Andres JF, White FC, Bloor CM.
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):481-4. PubMed ID: 4818387
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical pathophysiological studies on coronary circulation. 3. The effects of so-called coronary vasodilator agents on coronary circulation in various diseases].
    Osugi S.
    Jpn Circ J; 1971 Feb; 35(2):268-80. PubMed ID: 5109720
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Pharmacodynamic effect on coronary blood circulation and metabolism of the human heart. Studies with 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromen)-hydrochloride].
    Rudolph W, Meixner L, Künzig HJ.
    Klin Wochenschr; 1967 Apr 01; 45(7):333-53. PubMed ID: 5585313
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.